Lily Holden, from Bristol, was first prescribed a topical steroid cream in 2014 after returning from an outdoor adventure ...
An international team of investigators has reported results from the first Phase III clinical trials of rocatinlimab, a novel treatment for moderate-to-severe atopic dermatitis (eczema).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback